Feature Verisante to seek FDA approval of Aura skin cancer device By Len Zehr In addition to ramping up distribution of its Aura non-invasive skin cancer detection device this year, Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) is preparing the process to seek FDA approval of Aura... June 11, 2013